Nikas IP - Search Results

1

The application of high-throughput proteomics in cytopathology.

Nikas IP, Ryu HS. Nikas IP, et al. J Pathol Transl Med. 2022 Nov;56(6):309-318. doi: 10.4132/jptm.2022.08.30. Epub 2022 Nov 9. J Pathol Transl Med. 2022. PMID: 36345621 Free PMC article. Review.

2

Viewing the Eph receptors with a focus on breast cancer heterogeneity.

Nikas I, Ryu HS, Theocharis S. Nikas I, et al. Cancer Lett. 2018 Oct 10;434:160-171. doi: 10.1016/j.canlet.2018.07.030. Epub 2018 Jul 25. Cancer Lett. 2018. PMID: 30055288 Review.

3

Serine-Arginine Protein Kinase 1 (SRPK1) as a Prognostic Factor and Potential Therapeutic Target in Cancer: Current Evidence and Future Perspectives.

Nikas IP, Themistocleous SC, Paschou SA, Tsamis KI, Ryu HS. Nikas IP, et al. Cells. 2019 Dec 19;9(1):19. doi: 10.3390/cells9010019. Cells. 2019. PMID: 31861708 Free PMC article. Review.

4

The Role of Nicotinamide in Cancer Chemoprevention and Therapy.

Nikas IP, Paschou SA, Ryu HS. Nikas IP, et al. Biomolecules. 2020 Mar 20;10(3):477. doi: 10.3390/biom10030477. Biomolecules. 2020. PMID: 32245130 Free PMC article. Review.

5

Molecular Profiling of Malignant Pleural Effusions with Next Generation Sequencing (NGS): Evidence that Supports Its Role in Cancer Management.

Grigoriadou GΙ, Esagian SM, Ryu HS, Nikas IP. Grigoriadou GΙ, et al. Among authors: nikas ip. J Pers Med. 2020 Nov 1;10(4):206. doi: 10.3390/jpm10040206. J Pers Med. 2020. PMID: 33139621 Free PMC article. Review.

6

Evaluating Infectious, Neoplastic, Immunological, and Degenerative Diseases of the Central Nervous System with Cerebrospinal Fluid-Based Next-Generation Sequencing.

Tsamis KI, Sakkas H, Giannakis A, Ryu HS, Gartzonika C, Nikas IP. Tsamis KI, et al. Among authors: nikas ip. Mol Diagn Ther. 2021 Mar;25(2):207-229. doi: 10.1007/s40291-021-00513-x. Epub 2021 Mar 1. Mol Diagn Ther. 2021. PMID: 33646562 Free PMC article. Review.

7

Biomarkers expression among paired serous ovarian cancer primary lesions and their peritoneal cavity metastases in treatment-naïve patients: A single-center study.

Nikas IP, Lee C, Song MJ, Kim B, Ryu HS. Nikas IP, et al. Cancer Med. 2022 Jun;11(11):2193-2203. doi: 10.1002/cam4.4600. Epub 2022 Feb 25. Cancer Med. 2022. PMID: 35212471 Free PMC article.

8

Nicotinamide (niacin) supplement increases lipid metabolism and ROS-induced energy disruption in triple-negative breast cancer: potential for drug repositioning as an anti-tumor agent.

Jung M, Lee KM, Im Y, Seok SH, Chung H, Kim DY, Han D, Lee CH, Hwang EH, Park SY, Koh J, Kim B, Nikas IP, Lee H, Hwang D, Ryu HS. Jung M, et al. Among authors: nikas ip. Mol Oncol. 2022 May;16(9):1795-1815. doi: 10.1002/1878-0261.13209. Epub 2022 Mar 25. Mol Oncol. 2022. PMID: 35278276 Free PMC article.

9

Proteomic-Based Machine Learning Analysis Reveals PYGB as a Novel Immunohistochemical Biomarker to Distinguish Inverted Urothelial Papilloma From Low-Grade Papillary Urothelial Carcinoma With Inverted Growth.

Jung M, Lee C, Han D, Kim K, Yang S, Nikas IP, Moon KC, Kim H, Song MJ, Kim B, Lee H, Ryu HS. Jung M, et al. Among authors: nikas ip. Front Oncol. 2022 Mar 24;12:841398. doi: 10.3389/fonc.2022.841398. eCollection 2022. Front Oncol. 2022. PMID: 35402263 Free PMC article.

10

Artificial intelligence system shows performance at the level of uropathologists for the detection and grading of prostate cancer in core needle biopsy: an independent external validation study.

Jung M, Jin MS, Kim C, Lee C, Nikas IP, Park JH, Ryu HS. Jung M, et al. Among authors: nikas ip. Mod Pathol. 2022 Oct;35(10):1449-1457. doi: 10.1038/s41379-022-01077-9. Epub 2022 Apr 29. Mod Pathol. 2022. PMID: 35487950 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

50 results

Search Page